⚠ COVID-19 INFORMATION: Resources, Vaccine Information

A Phase 1, Open-label, Multicenter Study to Determine the Pharmacokinetics and Safety of Intravenous Eravacycline in Children With Suspected or Confirmed Bacterial Infection

Official Title: A Phase 1, Open-label, Multicenter Study to Determine the Pharmacokinetics and Safety of Intravenous Eravacycline in Children With Suspected or Confirmed Bacterial Infection

This is a Phase 1, open-label, single dose study to evaluate PK, safety, and tolerability of IV eravacycline in children with suspected or confirmed bacterial infection who are receiving systemic antibiotic therapy, other than eravacycline. The study design will allow for evaluation of PK and safety of IV eravacycline in a pediatric population at exposures predicted to be comparable to those already studied in adults.

ClinicalTrials.gov ID: NCT03696550

Principal Investigator: Muller, William J., MD, PhD

Study Type: Interventional

Currently Recruiting Patients: Yes

Contact Information:

Laura Fearn

Research Nurse

312.227.6285